Ningbo Institute of Industrial Technology

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Showing 10 of 2,066 papers

Research Article
10.1016/j.triboint.2026.111961

Tailored core - shell sulfonated carbon dots with functional shells for enhanced lubrication and anticorrosion

Aug 01, 2026
Tribology International
Ting Ying + 15 more +15

Research Article
2
10.1016/j.jmst.2025.10.040

Enhanced thermal conductivity of reaction-bonded silicon carbide via constructing a mesoporous carbon network in preform

Aug 01, 2026
Journal of Materials Science & Technology
Quanxing Ren + 9 more +9

Research Article
10.1016/j.tws.2026.114791

Multiscale mechanical behavior and failure mechanisms of PEEK-lined braided composite tubes: Delayed damage at the aeronautical component level

Jul 01, 2026
Thin-Walled Structures
Xin Xie + 7 more +7

Research Article
10.1016/j.jcp.2026.114786

On a class of higher-order length preserving and energy decreasing IMEX schemes for the Landau-Lifshitz equation

Jun 01, 2026
Journal of Computational Physics
Xiaoli Li + 2 more +2

Research Article
1
10.1016/j.apenergy.2026.127724

Eco-friendly energy management strategy for turbo-electric eVTOLs: Coupling fuel economy, battery health and life-cycle emissions via improved TD3

Jun 01, 2026
Applied Energy
Feifan Yu + 6 more +6

Research Article
10.1016/j.msea.2026.150042

Cyclic deep cryogenic treatment enables improved mechanical properties and residual stress in additively manufactured CrCoNi medium-entropy alloy

May 01, 2026
Materials Science and Engineering: A
Wenjie Zhao + 10 more +10

Research Article
10.1016/j.jmrt.2026.03.217

Low cycle fatigue behaviors and damage mechanisms of Mo-alloyed CrCoNi medium entropy alloy

May 01, 2026
Journal of Materials Research and Technology
Aihua Han + 6 more +6

Research Article
10.1016/j.media.2026.103996

Generative data-engine foundation model for universal few-shot 2D vascular image segmentation.

May 01, 2026
Medical image analysis
Rongjun Ge + 10 more +10

Research Article
10.1016/j.matlet.2026.140243

Surface-reconstructed porous PI/BaFe12O19/CS coatings with thickness-insensitive microwave absorption

May 01, 2026
Materials Letters
Pengyu Li + 5 more +5

Research Article
10.1016/j.jconrel.2026.114809

Dual-action nasal spray with mussel protein and xylitol restores epithelial barrier and attenuates type 2 inflammation in allergic rhinitis.

May 01, 2026
Journal of controlled release : official journal of the Controlled Release Society
Bin Zhang + 5 more +5

Allergic rhinitis (AR) is a prevalent chronic inflammatory disorder of the upper airways, driven by Th2-mediated immune dysregulation and compromised epithelial barrier function. Current therapies, such as intranasal corticosteroids, often exhibit limited efficacy and adverse effects upon prolonged use. Herein, we developed a novel dual-action nasal spray, termed Mefp, by combining mussel adhesive protein (MAP) and xylitol to simultaneously target epithelial barrier repair and inflammatory pathways. The Mefp formulation exhibited strong mucoadhesive properties, with nasal retention lasting up to 24h, facilitated by catechol-mediated adhesion of 3,4-dihydroxyphenylalanine (DOPA) residues in MAP. In vitro experiments using LPS-stimulated human nasal epithelial cells (HNEpCs) demonstrated that Mefp significantly restored tight junction proteins (ZO-1 and occludin), suppressed NF-κB activation, reduced oxidative stress, and attenuated the release of pro-inflammatory (TNF-α, IL-6) and Th2 cytokines (IL-4, IL-5, IL-13). In an ovalbumin-induced murine AR model, Mefp treatment markedly alleviated allergic symptoms, reduced eosinophil infiltration, decreased OVA-specific IgE levels, and enhanced antioxidant enzyme activities. Histological and immunofluorescence analyses confirmed the restoration of mucosal integrity and tight junction assembly. Notably, Mefp demonstrated comparable or superior efficacy to mometasone furoate (MF) in alleviating allergic symptoms and suppressing key inflammatory mediators, while showing a better safety profile regarding epithelial integrity in vitro. These findings indicate that Mefp effectively addresses both epithelial barrier dysfunction and type 2 inflammation, offering a promising and safe therapeutic strategy for AR.